Author:
Santos Marina,García Lia C.,Checura Cintia,Donadío Lucía Gandolfi,Fernandez Carlos,Orgueira Hernán,Comin Maria J.
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference12 articles.
1. MULTAQ® (DRONEDARONE), Advis. Comm. Meet. Cardiovasc. Ren. Drugs Div US Food Drug Adm.. (2009); http://www.fda.gov/ohrms/dockets/ac/09/briefing/2009-4417b1-02-sanofi_aventis.pdf
2. Dronedarone for atrial fibrillation — an odyssey;Zimetbaum;N. Engl. J. Med.,2009
3. Dronedarone for atrial fibrillation: a new therapeutic agent;Patel;Vasc. Health Risk Manage.,2009
4. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter;Singh;N. Engl. J. Med.,2007
5. ICH harmonized tripartite guideline, Impurities in New Drug Substances Q3A (R2), current step 4th version, October 25, 2006, n.d.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献